Silibinin ameliorates hepatic lipid accumulation and oxidative stress in mice with non-alcoholic steatohepatitis by regulating CFLAR-JNK pathway

Autor: Wei Xu, You Jiaojiao, Yong Chen, Yayun Liu, Ting Zhai
Rok vydání: 2019
Předmět:
Lipid accumulation
AST
aspartate aminotransferase

HO-1
heme oxygenase 1

Pharmacology
Gpat
glycerol-3-phosphate acyltransferase

medicine.disease_cause
PI3K
phosphatidylinositol 3-hydroxy kinase

chemistry.chemical_compound
pIRS1
phosphorylation of insulin receptor substrate 1

0302 clinical medicine
IR
insulin resistance

Pnpla3
phospholipase domain containing 3

Mttp
microsomal triglyceride transfer protein

General Pharmacology
Toxicology and Pharmaceutics

0303 health sciences
TG
triglyceride

NASH
CYP2E1
cytochrome P450 2E1

HE
hematoxylin–eosin

CYP2E1
Fabp5
fatty acid-binding proteins 5

pJNK
phosphorylation of c-Jun N-terminal kinase

030220 oncology & carcinogenesis
JNK
c-Jun N-terminal kinase

NRF2
nuclear factor erythroid 2-related factor 2

IRS1
insulin receptor substrate 1

NF-κB
nuclear factor κB

Pparα
peroxisome proliferator activated receptor α

NASH
nonalcoholic steatohepatitis

Original article
NAFLD
non-alcoholic fatty liver disease

GSH-Px
glutathione peroxidase

MT
Masson–Trichrome

CFLAR
caspase 8 and Fas-associated protein with death domain-like apoptosis regulator

MCS
methionine- and choline-sufficient

Silibinin
Cpt1α
carnitine palmitoyl transferase 1α

CFLAR
PA
palmitic acid

03 medical and health sciences
In vivo
ALT
alanine aminotransferase

CYP4A
cytochrome P450 4A

medicine
Srebp-1c
sterol regulatory element binding protein-1C

Acox
acyl-coenzyme A oxidase X

Oxidation stress
030304 developmental biology
MCD
methionine- and choline-deficient

MDA
malondialdehyde

Methionine
lcsh:RM1-950
OA
oleic acid

2-NBDG
2-(N-(7-nitrobenz-2-oxa-1
3-diazol-4-yl) amino)-2-deoxyglucose

Lipid metabolism
Scd-1
stearoyl-coenzyme A desaturase-1

medicine.disease
TC
total cholesterol

lcsh:Therapeutics. Pharmacology
chemistry
ORO
oil red O

SD
Sprague–Dawley

CAT
catalase

Steatohepatitis
Akt
serine–threonine protein kinase

MAPK
mitogen-activated protein kinase

Oxidative stress
Zdroj: Acta Pharmaceutica Sinica B, Vol 9, Iss 4, Pp 745-757 (2019)
Acta Pharmaceutica Sinica. B
ISSN: 2211-3835
DOI: 10.1016/j.apsb.2019.02.006
Popis: Non-alcoholic steatohepatitis (NASH) is a chronic metabolic syndrome and the CFLAR-JNK pathway can reverse the process of NASH. Although silibinin is used for the treatment of NASH in clinical, its effect on CFLAR-JNK pathway in NASH remains unclear. This study aimed to investigate the effect of silibinin on CFLAR-JNK pathway in NASH models both in vivo and in vitro. The in vivo study was performed using male C57BL/6 mice fed with methionine– choline-deficient diet and simultaneously treated with silibinin for 6 weeks. The in vitro study was performed by using mouse NCTC-1469 cells which were respectively pretreated with oleic acid plus palmitic acid, and adenovirus-down Cflar for 24 h, then treated with silibinin for 24 h. After the drug treatment, the key indicators involved in CFLAR-JNK pathway including hepatic injury, lipid metabolism and oxidative stress were determined. Silibinin significantly activated CFLAR and inhibited the phosphorylation of JNK, up-regulated the mRNA expression of Pparα, Fabp5, Cpt1α, Acox, Scd-1, Gpat and Mttp, reduced the activities of serum ALT and AST and the contents of hepatic TG, TC and MDA, increased the expression of NRF2 and the activities of CAT, GSH-Px and HO-1, and decreased the activities and expression of CYP2E1 and CYP4A in vivo. These effects were confirmed by the in vitro experiments. Silibinin prevented NASH by regulating CFLAR-JNK pathway, and thereby on one hand promoting the β-oxidation and efflux of fatty acids in liver to relieve lipid accumulation, and on the other hand inducing antioxidase activity (CAT, GSH-Px and HO-1) and inhibiting pro-oxidase activity (CYP2E1 and CYP4A) to relieve oxidative stress.
Graphical abstract Silibinin could regulate CFLAR-JNK pathway to ameliorates hepatic lipid accumulation, insulin resistence and oxidative stress in C57BL/6 mice treated by methionine- and choline-deficient diet, and NCTC-1469 cells treated by the mixture of oleic acid and palmitic acid and adenovirus-down Cflar.fx1
Databáze: OpenAIRE